From The Motley Fool · The Motley Fool Team · · 50s
Abbott Spins Off Nutrition for Long-Term Growth
Abbott spins off nutrition business to focus on high-margin medical tech and diagnostics.
In brief
Abbott spins off nutrition business to focus on high-margin medical tech and diagnostics. Abbott plans to spin off its nutrition division to boost medical device growth and margins for long-term investors. Originally reported by The Motley Fool.
Spinning Off Nutrition Isolates High-Margin Healthcare Growth
Abbott plans to spin off its nutrition business into an independent public company on Oct 21, 2026.
“Separating adult and pediatric nutrition creates a pure-play consumer health business while shifting the remaining portfolio toward faster-growing medical devices and diagnostics.”
Cancer Diagnostics Drive Core Testing Revenue Acceleration
Cologuard and precision oncology tools boosted cancer diagnostics sales by 14% in Q3 2026.
“In cancer diagnostics, sales growth of 14% was driven by Cologuard and contributions to growth from our precision oncology and international businesses.”
Pulsed Field Ablation Powers Electrophysiology Expansion
New catheter technology and regulatory approvals accelerate electrophysiology market share gains.
“Growth was well-balanced across the portfolio, led by double-digit growth in electrophysiology and rhythm management.”
Spinning Off Nutrition Sharpens Corporate Focus
Spinning off nutrition boosts medical device sales and margins while preserving dividend continuity.
“Spinning off the nutrition division sharpens the corporate structure around high-margin technology, directing capital toward high-return medical research while preserving dividend continuity and balance sheet strength.”
The short version
Abbott plans to spin off its nutrition division to boost medical device growth and margins for long-term investors.
